650
Participants
Start Date
June 1, 2025
Primary Completion Date
September 30, 2026
Study Completion Date
December 31, 2026
The result of the Polygenic Risk Score will be communicated to the patient with the aim of encouraging a change in behavior
Blood samples collected for the calculation of the genetic predisposition profile for Cardiovascular risk will be used for DNA extraction and genotyping, and the PRS will subsequently be calculated. Based on the results, individuals will be classified into three main CVD risk categories (high risk, intermediate risk, low risk)
RECRUITING
Dipartimento Universitario di Scienze della Vita e Sanità Pubblica, Roma
Catholic University of the Sacred Heart
OTHER